Accuray reported $199.44M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 76.66M 30.28M Sep/2026
AtriCure USD 83.97M 2.06M Sep/2026
Boston Scientific USD 5.98B 446M Sep/2026
Edwards Lifesciences USD 1.58B 68.8M Sep/2026
Inogen USD 64.94M 2.12M Sep/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 138.38M 18.62M Sep/2026
Tandem Diabetes Care USD 256.08M 3.07M Sep/2026
Trinity Biotech USD 143.68M 2.48M Mar/2026